Effects of the COVID-19 Pandemic on Cardiac Surgery Practice and Outcomes |
Gopal, Kirun
(Department of Cardiovascular and Thoracic Surgery, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham (Amrita University))
Krishna, Neethu (Department of Cardiovascular and Thoracic Surgery, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham (Amrita University)) Jose, Rajesh (Department of Cardiovascular and Thoracic Surgery, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham (Amrita University)) Biju, Surya Sree Chitra (Department of Cardiovascular and Thoracic Surgery, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham (Amrita University)) Pichandi, Jaya Suriya (Department of Cardiovascular and Thoracic Surgery, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham (Amrita University)) Varma, Praveen Kerala (Department of Cardiovascular and Thoracic Surgery, Amrita Institute of Medical Sciences and Research Center, Amrita Vishwa Vidyapeetham (Amrita University)) |
1 | Tam CF, Cheung KS, Lam S, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes 2020;13:e006631. DOI |
2 | Osman F, Caplin N, Bashir M. COVID-19: the rising cost of cardiac surgery and disease. J Card Surg 2021;36:1593-6. DOI |
3 | Losurdo P, Paiano L, Samardzic N, et al. Impact of lockdown for SARS-CoV-2 (COVID-19) on surgical site infection rates: a monocentric observational cohort study. Updates Surg 2020;72:1263-71. DOI |
4 | Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020;109:531-8. DOI |
5 | Sanders J, Akowuah E, Cooper J, et al. Cardiac surgery outcome during the COVID-19 pandemic: a retrospective review of the early experience in nine UK centres. J Cardiothorac Surg 2021;16:43. DOI |
6 | Ahmad FB, Anderson RN. The leading causes of death in the US for 2020. JAMA 2021;325:1829-30. DOI |
7 | Zorzi A, Vio R, Rivezzi F, et al. Characteristics and hospital course of patients admitted for acute cardiovascular diseases during the coronavirus disease-19 outbreak. J Cardiovasc Med (Hagerstown) 2021;22:29-35. DOI |
8 | Young MN, Iribarne A, Malenka D. COVID-19 and cardiovascular health: this is a public service announcement. J Am Coll Cardiol 2021;77:170-2. |
9 | Wu J, Mamas MA, Mohamed MO, et al. Place and causes of acute cardiovascular mortality during the COVID-19 pandemic. Heart 2021;107:113-9. DOI |
10 | Wadhera RK, Shen C, Gondi S, Chen S, Kazi DS, Yeh RW. Cardiovascular deaths during the COVID-19 pandemic in the United States. J Am Coll Cardiol 2021;77:159-69. |
11 | Abdelaziz HK, Abdelrahman A, Nabi A, et al. Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: insights from a British cardiac center. Am Heart J 2020;226:45-8. DOI |
12 | Vervoort D, Luc JG, Percy E, Hirji S, Lee R. Assessing the collateral damage of the novel coronavirus: a call to action for the post-COVID-19 era. Ann Thorac Surg 2020;110:757-60. DOI |
13 | Haft JW, Atluri P, Ailawadi G, et al. Adult cardiac surgery during the COVID-19 pandemic: a tiered patient triage guidance statement. J Thorac Cardiovasc Surg 2020;160:452-5. DOI |
14 | COVIDSurg Collaborative. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet 2020;396:27-38. DOI |
15 | Harky A, Chen R, Pullan M. Examining the impact of COVID-19 on cardiac surgery services: the lessons learned from this pandemic. J Card Surg 2020;35:2364-6. DOI |
16 | Tomasoni D, Adamo M, Italia L, et al. Impact of COVID-2019 outbreak on prevalence, clinical presentation and outcomes of ST-elevation myocardial infarction. J Cardiovasc Med (Hagerstown) 2020;21:874-81. DOI |
17 | Khan IH, Savarimuthu S, Leung MS, Harky A. The need to manage the risk of thromboembolism in COVID-19 patients. J Vasc Surg 2020;72:799-804. DOI |
18 | Wilson SJ, Connolly MJ, Elghamry Z, et al. Effect of the COVID-19 pandemic on ST-segment-elevation myocardial infarction presentations and in-hospital outcomes. Circ Cardiovasc Interv 2020;13:e009438. DOI |
19 | Chikwe J, Gaudino M, Hameed I, et al. Committee Recommendations for Resuming Cardiac Surgery Activity in the SARS-CoV-2 Era: guidance from an International Cardiac Surgery Consortium. Ann Thorac Surg 2020;110:725-32. DOI |
20 | De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J 2020;41:2083-8. DOI |
21 | Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J 2020;41:1798-800. DOI |
22 | Nader J, Anselmi A, Tomasi J, et al. Adult cardiac surgery during COVID-19 lockdown: impact on activity and outcomes in a high-volume centre. Arch Cardiovasc Dis 2021;114:364-70. DOI |
23 | Menon JC, Rakesh PS, John D, Thachathodiyl R, Banerjee A. What was right about Kerala's response to the COVID-19 pandemic? BMJ Glob Health 2020;5:e003212. DOI |
24 | Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. DOI |
25 | Besnier E, Tuech JJ, Schwarz L. We asked the experts: covid-19 outbreak: is there still a place for scheduled surgery?: "reflection from pathophysiological data". World J Surg 2020;44:1695-8. DOI |
26 | Hiremath CS, Yadava OP, Meharwal ZS, Iyer KS, Velayudhan B; COVID-19 Task Force of the Indian Association of Cardiovascular-Thoracic Surgeons. IACTS guidelines: practice of cardiovascular and thoracic surgery in the COVID-19 era. Indian J Thorac Cardiovasc Surg 2020;36:1-13. |
![]() |